Your browser version may not work well with NCBI's Web applications. More information here...
1: Phytomedicine. 2001 Jul;8(4):267-74.Links

Persistent response to pneumococcal vaccine in individuals supplemented with a novel water soluble extract of Uncaria tomentosa, C-Med-100.

Lamm S, Sheng Y, Pero RW.

Department of Cell and Molecular Biology, Section of Tumor and Immune Biology, University of Lund, Sweden.

A human intervention study was carried out using male volunteers attending a General Practice Clinic in New York City involving comparison of individuals supplemented with 350 mg x 2 C-Med-100 daily dose for two months with untreated controls for their abilities to respond to a 23 valent pneumococcal vaccine. C-Med-100 is a novel nutraceutical extract from the South American plant Uncaria tomentosa or Cat's Claw which is known to possess immune enhancing and antiinflammatory properties in animals. There were no toxic side effects observed as judged by medical examination, clinical chemistry and blood cell analysis. However, statistically significant immune enhancement for the individuals on C-Med-100 supplement was observed by (i) an elevation in the lymphocyte/neutrophil ratios of peripheral blood and (ii) a reduced decay in the 12 serotype antibody titer responses to pneumococcal vaccination at 5 months.

PMID: 11515716 [PubMed - indexed for MEDLINE]

Patient Drug Information

  • Pneumococcal Polysaccharide Vaccine (Pneumovax® 23)

    Pneumococcal disease is caused byStreptococcus pneumoniae bacteria. It is a leading cause of vaccine-preventable illness and death in the United States. Anyone can get pneumococcal disease, but some people are at greater...

  • Source: AHFS Consumer Medication Information